Comparison of artemether-lumefantrine and chloroquine with and without primaquine for the treatment of Plasmodium vivax infection in Ethiopia: A randomized controlled trial
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“With the exception of data from a location in Arbaminch in 2008, where efficacy was reported to be 92.5% (Personal communication, Moges Kassa), AL efficacy remained greater than 95% against uncomplicated P. falciparum throughout the country since the beginning of its use in 2004 [6–10].”
In the citing paper
“Studies conducted since 2006 by EPHI and others have shown a high efficacy of AL against P. falciparum, confirming the drug remains well-tolerated and effective for the intended use in Ethiopia [4, 5, 8–10, 15, 19, 34, 35].”
In the citing paper
“In Ethiopia, CQ efficacy remains above 95% although sporadic reports of CQ failure suggest emerging resistance [8, 13–20].”
In the citing paper
“which is consistent with prior studies in Ethiopia as well as the findings of a systematic review of DHA/PPQ treatment for P. vivax [8, 40]”
In the citing paper
“The addition of primaquine for radical cure which is now included in the revised national malaria treatment guideline of Ethiopia will not only address relapse prevention but should further enhance the schizonticidal efficacy of CQ [8, 44].”
14 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bruxvoort, K., Goodman, C., Kachur, S. P., & Schellenberg, D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084555 · Cited by 135
Self-citation
Research works printed but not linked: 31
- CA Guerra, 2010, The international limits and population at risk of Plasmodium vivax transmission in 2009, PLoS Negl Trop Dis, 4, e774, 10.1371/journal.pntd.0000774 · DOI · Paper page
- RN Price, 2007, Vivax malaria: neglected and not benign, Am J Trop Med Hyg, 77, 79, 10.4269/ajtmh.2007.77.79 · DOI · Paper page
- RN Price, 2014, Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis, Lancet Infect Dis, 14, 982, 10.1016/S1473-3099(14)70855-2 · DOI · Paper page
- NM Douglas, 2014, Mortality attributable to Plasmodium vivax malaria: a clinical audit from Papua, Indonesia, BMC Med, 12, 217, 10.1186/s12916-014-0217-z · DOI
- RN Price, 2009, New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance, Curr Opin Infect Dis, 22, 430, 10.1097/QCO.0b013e32832f14c1 · DOI · Paper page
- W Nigatu, 1992, Plasmodium vivax and P. falciparum epidemiology in Gambella, south-west Ethiopia, Trop Med Parasitol, 43, 181
- D Olana, 2011, Malaria, Oromia regional state, Ethiopia, 2001–2006, Emerg Infect Dis, 17, 1336, 10.3201/eid1707.100942 · DOI
- J Manuel Ramos, 2005, Change in epidemiology of malaria infections in a rural area in Ethiopia, J Travel Med, 12, 155, 10.2310/7060.2005.12304 · DOI
- NW Lucchi, 2014, PET-PCR method for the molecular detection of malaria parasites in a national malaria surveillance study in Haiti, 2011, Malar J, 13, 462, 10.1186/1475-2875-13-462 · DOI
- M Imwong, 2007, Contrasting genetic structure in Plasmodium vivax populations from Asia and South America, Int J Parasitol, 37, 1013, 10.1016/j.ijpara.2007.02.010 · DOI · Paper page
- DA Joy, 2008, Local adaptation and vector-mediated population structure in Plasmodium vivax malaria, Mol Biol Evol, 25, 1245, 10.1093/molbev/msn073 · DOI · Paper page
- LC Patchen, 1983, Analysis of filter-paper-absorbed, finger-stick blood samples for chloroquine and its major metabolite using high-performance liquid chromatography with fluorescence detection, J Chromatogr, 278, 81, 10.1016/S0378-4347(00)84758-1 · doi:10.1016/s0378-4347(00)84758-1
- S Pukrittayakamee, 2014, Pharmacokinetic interactions between primaquine and chloroquine, Antimicrob Agents Chemother, 58, 3354, 10.1128/AAC.02794-13 · doi:10.1128/aac.02794-13
- M Cabrera, 2015, In vitro activities of primaquine-schizonticide combinations on asexual blood stages and gametocytes of Plasmodium falciparum, Antimicrob Agents Chemother, 59, 7650, 10.1128/AAC.01948-15 · doi:10.1128/aac.01948-15
- RN Price, 2012, Phenotypic and genotypic characterisation of drug-resistant Plasmodium vivax, Trends Parasitol, 28, 522, 10.1016/j.pt.2012.08.005 · DOI
- SK Mekonnen, 2014, Return of chloroquine-sensitive Plasmodium falciparum parasites and emergence of chloroquine-resistant Plasmodium vivax in Ethiopia, Malar J, 13, 244, 10.1186/1475-2875-13-244 · DOI · Paper page
- M Schunk, 2006, High prevalence of drug-resistance mutations in Plasmodium falciparum and Plasmodium vivax in southern Ethiopia, Malar J, 5, 54, 10.1186/1475-2875-5-54 · DOI
- S Getachew, 2015, Chloroquine efficacy for Plasmodium vivax malaria treatment in southern Ethiopia, Malar J, 14, 525, 10.1186/s12936-015-1041-4 · DOI · Paper page
- T Ketema, 2011, Therapeutic efficacy of chloroquine for treatment of Plasmodium vivax malaria cases in Halaba district, South Ethiopia, Parasit Vectors, 4, 46, 10.1186/1756-3305-4-46 · DOI · Paper page
- JK Baird, 2004, Chloroquine resistance in Plasmodium vivax, Antimicrob Agents Chemother, 48, 4075, 10.1128/AAC.48.11.4075-4083.2004 · DOI · Paper page
- NJ White, 2011, Determinants of relapse periodicity in Plasmodium vivax malaria, Malar J, 10, 297, 10.1186/1475-2875-10-297 · DOI · Paper page
- HA Karunajeewa, 2008, A trial of combination antimalarial therapies in children from Papua New Guinea, N Engl J Med, 359, 2545, 10.1056/NEJMoa0804915 · DOI · Paper page
- JK Baird, 2003, Can primaquine therapy for vivax malaria be improved?, Trends Parasitol, 19, 115, 10.1016/S1471-4922(03)00005-9 · DOI · Paper page
- GK John, 2012, Primaquine radical cure of Plasmodium vivax: a critical review of the literature, Malar J, 11, 280, 10.1186/1475-2875-11-280 · DOI · Paper page
- KP Grietens, 2010, Adherence to 7-day primaquine treatment for the radical cure of P. vivax in the Peruvian Amazon, Am J Trop Med Hyg, 82, 1017, 10.4269/ajtmh.2010.09-0521 · DOI
- N Khantikul, 2009, Adherence to antimalarial drug therapy among vivax malaria patients in northern Thailand, J Health Popul Nutr, 27, 4, 10.3329/jhpn.v27i1.3313 · DOI · Paper page
- EA Pereira, 2011, Adherence to Plasmodium vivax malaria treatment in the Brazilian Amazon Region, Malar J, 10, 355, 10.1186/1475-2875-10-355 · DOI · Paper page
- R Takeuchi, 2010, Directly-observed therapy (DOT) for the radical 14-day primaquine treatment of Plasmodium vivax malaria on the Thai-Myanmar border, Malar J, 9, 308, 10.1186/1475-2875-9-308 · DOI
- T Leslie, 2004, Compliance with 14-day primaquine therapy for radical cure of vivax malaria—a randomized placebo-controlled trial comparing unsupervised with supervised treatment, Trans R Soc Trop Med Hyg, 98, 168, 10.1016/S0035-9203(03)00041-5 · DOI · Paper page
- L von Seidlein, 2013, Review of key knowledge gaps in glucose-6-phosphate dehydrogenase deficiency detection with regard to the safe clinical deployment of 8-aminoquinoline treatment regimens: a workshop report, Malar J, 12, 112, 10.1186/1475-2875-12-112 · DOI · Paper page
- NM Douglas, 2013, Major burden of severe anemia from non-falciparum malaria species in Southern Papua: a hospital-based surveillance study, PLoS Med, 10, e1001575, 10.1371/journal.pmed.1001575 · DOI · Paper page
Cited by
Assefa, A., Ali, A., Deressa, W., Tsegaye, W., Abebe, G., Sime, H., Kebede, A., Jima, D., Kassa, M., Abreha, T., et al. (2018) · Malaria Journal · doi:10.1186/s12936-018-2538-4 · Cited by 34
Self-citationAssefa, A., Mohammed, H., Anand, A., Abera, A., Sime, H., Minta, A. A., Tadesse, M., Tadesse, Y., Girma, S., Bekele, W., et al. (2022) · Malaria Journal · doi:10.1186/s12936-022-04350-z · Cited by 20
Self-citationDegaga, T. S., Sime, H., Ruybal-Pesántez, S., Osborne, A., Mwaura, M., Bamboro, S. A., Mnjala, H., Mekonnen, G., Ermias, S., Fantahun, A., et al. (2026) · Malaria Journal · doi:10.1186/s12936-026-06050-4 · Cited by 1
Self-citationOsborne, A. A., Ruybal-Pesantez, S., Rai, A., Trimarsanto, H., Hoon, K. S., Piera, K., Kleinecke, M., Rumaseb, A., Sutanto, E., Thriemer, K., et al. (2026) · doi:10.64898/2026.11.12.765293
Self-citationShifraw, T., Abdelmenan, S., Zewde, A., Worku, A., Abera, A., Mohammed, H., Etana, K., Keating, J., Chibsa, S., Girma, S., et al. (2025) · Malaria Journal · doi:10.1186/s12936-025-05709-8
Self-citation
Metadata
- Authors
- Abreha, T., Hwang, J., Thriemer, K., Tadesse, Y., Girma, S., Melaku, Z., Assef, A., Kassa, M., Chatfield, M. D., Landman, K. Z., Chenet, S. M., Lucchi, N. W., Udhayakumar, V., Zhou, Z., Shi, Y. P., Kachur, S. P., Jima, D., Kebede, A., Solomon, H., Mekasha, A., Alemayehu, B. H., Malone, J. L., Dissanayake, G., Teka, H., Auburn, S., von Seidlein, L., & Price, R. N.
- Venue
- PLOS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2017-05-16
- Volume
- 14
- Issue
- 5
- Pages
- e1002299
- ISSN
- 1549-1676
- Cited by
- 82
- References
- 1
- Language
- en
- Update notices
- correction (2018-10-04)
- Funders
- U.S. President's Malaria Initiative (Ethiopia Fiscal Year 2012 Budget)
- Bill and Melinda Gates Foundation (OPP1054404)
- Wellcome Trust (200909)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.